D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Stress Disorder, Post Traumatic

In brief

This study will determine whether a combination of virtual reality exposure therapy and D-cycloserine will reduce post-traumatic stress disorder symptoms in Iraq war veterans.

Key facts

Study ID

NCT00356278

Run by

Emory University

People needed

156

Starts

2006-09-01

Expected to finish

2014-06-01

Last updated by the study team

2016-01-08

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV criteria for PTSD due to Iraq military trauma
• Speaks English
• Healthy overall

You may not qualify if…

• History of mania, schizophrenia, or other psychoses
• Suicidal
• Current alcohol or drug dependence
• Medication free within 2 weeks of study entry for any medication that has been taken less than daily for the past month and medicine free within 4 weeks of study entry for any anxiolytic medication that has been taken daily for the last month or more
• Pregnant
• Special medical conditions, such as kidney insufficiency, chronic diseases, or history of significant head injury
• Stabilized on potentially data obscuring medication such as glucocorticoids

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.